Apogee Therapeutics, Inc.
APGE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $108 | $124 | $107 | $142 |
| Short-Term Investments | $419 | $381 | $406 | $379 |
| Receivables | $4 | $4 | $5 | $5 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $8 | $7 | $3 | $4 |
| Total Curr. Assets | $540 | $516 | $522 | $530 |
| Property Plant & Equip (Net) | $16 | $17 | $17 | $13 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $62 | $116 | $168 | $210 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $9 | $9 | $7 | $0 |
| Total NC Assets | $86 | $142 | $193 | $224 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $626 | $658 | $714 | $754 |
| Liabilities | – | – | – | – |
| Payables | $0 | $6 | $2 | $1 |
| Short-Term Debt | $4 | $4 | $4 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $30 | $22 | $27 | $24 |
| Total Curr. Liab. | $34 | $32 | $33 | $29 |
| LT Debt | $6 | $7 | $8 | $9 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $6 | $7 | $8 | $9 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $10 | $7 | $8 | $9 |
| Total Liabilities | $40 | $38 | $41 | $37 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$492 | -$427 | -$361 | -$306 |
| AOCI | $1 | $1 | $1 | $1 |
| Other Equity | $1,078 | $1,046 | $1,034 | $1,022 |
| Total Equity | $586 | $619 | $673 | $717 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $626 | $658 | $714 | $754 |
| Net Debt | -$98 | -$113 | -$95 | -$130 |